[go: up one dir, main page]

GB9916794D0 - In vitro virus reconstitution - Google Patents

In vitro virus reconstitution

Info

Publication number
GB9916794D0
GB9916794D0 GBGB9916794.2A GB9916794A GB9916794D0 GB 9916794 D0 GB9916794 D0 GB 9916794D0 GB 9916794 A GB9916794 A GB 9916794A GB 9916794 D0 GB9916794 D0 GB 9916794D0
Authority
GB
United Kingdom
Prior art keywords
vitro virus
virus reconstitution
reconstitution
vitro
virus
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Ceased
Application number
GBGB9916794.2A
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Oxford University Innovation Ltd
Original Assignee
Oxford University Innovation Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Oxford University Innovation Ltd filed Critical Oxford University Innovation Ltd
Priority to GBGB9916794.2A priority Critical patent/GB9916794D0/en
Publication of GB9916794D0 publication Critical patent/GB9916794D0/en
Priority to DE200712000070 priority patent/DE122007000070I1/en
Priority to CA2379012A priority patent/CA2379012C/en
Priority to ES00946097T priority patent/ES2278621T5/en
Priority to JP2001509537A priority patent/JP4850375B2/en
Priority to AT00946097T priority patent/ATE353370T1/en
Priority to AU59984/00A priority patent/AU5998400A/en
Priority to DE122008000056C priority patent/DE122008000056I1/en
Priority to DK00946097.3T priority patent/DK1194580T4/en
Priority to PT00946097T priority patent/PT1194580E/en
Priority to DE200712000061 priority patent/DE122007000061I2/en
Priority to DE60033284.5T priority patent/DE60033284T3/en
Priority to DE122008000057C priority patent/DE122008000057I1/en
Priority to DE201112100041 priority patent/DE122011100041I1/en
Priority to PCT/GB2000/002710 priority patent/WO2001004333A1/en
Priority to EP00946097A priority patent/EP1194580B2/en
Priority to CY20071100397T priority patent/CY1106404T1/en
Priority to NL300301C priority patent/NL300301I2/en
Priority to CY200700023C priority patent/CY2007023I2/en
Priority to LU91367C priority patent/LU91367I2/en
Priority to NL300294C priority patent/NL300294I2/en
Priority to NL300369C priority patent/NL300369I1/en
Priority to NL300368C priority patent/NL300368I2/en
Priority to FR08C0046C priority patent/FR08C0046I2/en
Ceased legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N7/00—Viruses; Bacteriophages; Compositions thereof; Preparation or purification thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A61P31/14—Antivirals for RNA viruses
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A61P31/14—Antivirals for RNA viruses
    • A61P31/16—Antivirals for RNA viruses for influenza or rhinoviruses
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
    • C12N15/09—Recombinant DNA-technology
    • C12N15/63—Introduction of foreign genetic material using vectors; Vectors; Use of hosts therefor; Regulation of expression
    • C12N15/79—Vectors or expression systems specially adapted for eukaryotic hosts
    • C12N15/85—Vectors or expression systems specially adapted for eukaryotic hosts for animal cells
    • C12N15/86—Viral vectors
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/51—Medicinal preparations containing antigens or antibodies comprising whole cells, viruses or DNA/RNA
    • A61K2039/525—Virus
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/51—Medicinal preparations containing antigens or antibodies comprising whole cells, viruses or DNA/RNA
    • A61K2039/525—Virus
    • A61K2039/5256—Virus expressing foreign proteins
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2710/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA dsDNA viruses
    • C12N2710/00011—Details
    • C12N2710/20011—Papillomaviridae
    • C12N2710/20051—Methods of production or purification of viral material
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2760/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA ssRNA viruses negative-sense
    • C12N2760/00011—Details
    • C12N2760/16011—Orthomyxoviridae
    • C12N2760/16034—Use of virus or viral component as vaccine, e.g. live-attenuated or inactivated virus, VLP, viral protein
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2760/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA ssRNA viruses negative-sense
    • C12N2760/00011—Details
    • C12N2760/16011—Orthomyxoviridae
    • C12N2760/16051—Methods of production or purification of viral material
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2760/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA ssRNA viruses negative-sense
    • C12N2760/00011—Details
    • C12N2760/16011—Orthomyxoviridae
    • C12N2760/16111—Influenzavirus A, i.e. influenza A virus
    • C12N2760/16151—Methods of production or purification of viral material
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2760/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA ssRNA viruses negative-sense
    • C12N2760/00011—Details
    • C12N2760/16011—Orthomyxoviridae
    • C12N2760/16111—Influenzavirus A, i.e. influenza A virus
    • C12N2760/16161—Methods of inactivation or attenuation

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Virology (AREA)
  • Chemical & Material Sciences (AREA)
  • Genetics & Genomics (AREA)
  • Organic Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • General Health & Medical Sciences (AREA)
  • Zoology (AREA)
  • Wood Science & Technology (AREA)
  • Biotechnology (AREA)
  • Biomedical Technology (AREA)
  • Medicinal Chemistry (AREA)
  • Molecular Biology (AREA)
  • General Engineering & Computer Science (AREA)
  • Oncology (AREA)
  • Microbiology (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Animal Behavior & Ethology (AREA)
  • Communicable Diseases (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Biochemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Plant Pathology (AREA)
  • Pulmonology (AREA)
  • Physics & Mathematics (AREA)
  • Biophysics (AREA)
  • Immunology (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
GBGB9916794.2A 1999-07-14 1999-07-16 In vitro virus reconstitution Ceased GB9916794D0 (en)

Priority Applications (24)

Application Number Priority Date Filing Date Title
GBGB9916794.2A GB9916794D0 (en) 1999-07-16 1999-07-16 In vitro virus reconstitution
EP00946097A EP1194580B2 (en) 1999-07-14 2000-07-14 In vitro reconstitution of segmented negative-strand rna viruses
DE200712000061 DE122007000061I2 (en) 1999-07-14 2000-07-14 In vitro reconstitution of segmented negative strand RNA viruses.
DE122008000057C DE122008000057I1 (en) 1999-07-14 2000-07-14 IN VITRO RECONSTITUTION OF SEGMENTED NEGATIVE RADIUS RNA VIRUSES
ES00946097T ES2278621T5 (en) 1999-07-14 2000-07-14 IN VITRO RECONSTRUCTION OF VIRUS ARN SEGMENTS OF NEGATIVE POLARITY.
JP2001509537A JP4850375B2 (en) 1999-07-14 2000-07-14 In vitro reconstruction of segmented (-) strand RNA virus
AT00946097T ATE353370T1 (en) 1999-07-14 2000-07-14 IN VITRO RECONSTITUTION OF SEGMENTED NEGATIVE STRAND RNA VIRUSES
AU59984/00A AU5998400A (en) 1999-07-14 2000-07-14 In vitro reconstitution of segmented negative-strand rna viruses
DE122008000056C DE122008000056I1 (en) 1999-07-14 2000-07-14 IN VITRO RECONSTITUTION OF SEGMENTED NEGATIVE RADIUS RNA VIRUSES
DK00946097.3T DK1194580T4 (en) 1999-07-14 2000-07-14 In-vitro reconstitution of segmented negative-stranded RNA viruses
PT00946097T PT1194580E (en) 1999-07-14 2000-07-14 In vitro reconstitution of segmented negative-strand rna viruses
DE200712000070 DE122007000070I1 (en) 1999-07-14 2000-07-14 In Vitro Reconstitution of Segmented Negative Strand Rna Viruses
DE60033284.5T DE60033284T3 (en) 1999-07-14 2000-07-14 IN VITRO RECONSTITUTION OF SEGMENTED NEGATIVE RADIATION RNA VIRUSES
CA2379012A CA2379012C (en) 1999-07-14 2000-07-14 In vitro reconstitution of segmented negative-strand rna viruses
DE201112100041 DE122011100041I1 (en) 1999-07-14 2000-07-14 In vitro reconstitution of segmented, negative-strand RNA viruses.
PCT/GB2000/002710 WO2001004333A1 (en) 1999-07-14 2000-07-14 In vitro reconstitution of segmented negative-strand rna viruses
CY20071100397T CY1106404T1 (en) 1999-07-14 2007-03-20 EPGASTRONIC RECOMBINATION OF NEGATIVE HELICAL RNA VIRUS SUBDIMENSIONS
NL300301C NL300301I2 (en) 1999-07-14 2007-09-21 In vitro reconstitution of RNA viruses with a segmented negative strand
CY200700023C CY2007023I2 (en) 1999-07-14 2007-09-21 EPGASTRONIC RECOMBINATION OF NEGATIVE-HELICAL RNA VIRUS SUBSCRIPTIZED DOMAIN
LU91367C LU91367I2 (en) 1999-07-14 2007-09-21 A complete inactivated influenza virus vaccine prepared from a germ strain produced by using reverse genetics and optionally including an adjuvant
NL300294C NL300294I2 (en) 1999-07-14 2007-09-21 In vitro reconstitution of RNA viruses with a segmented negative strand
NL300369C NL300369I1 (en) 1999-07-14 2008-11-13 In vitro reconstitution of RNA viruses with a segmented negative strand
NL300368C NL300368I2 (en) 1999-07-14 2008-11-13 Inactivated split influenza virus from influenza strain A / Indonesia / 05/2005 (H5N1) (PR8-IBCDC-RG2), if desired from a pandemic influenza strain in an officially declared pandemic situation
FR08C0046C FR08C0046I2 (en) 1999-07-14 2008-11-13 IN VITRO RECONSTRUCTION OF SEGMENTED POLARITY-NEGATIVE RNA VIRUSES

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
GBGB9916794.2A GB9916794D0 (en) 1999-07-16 1999-07-16 In vitro virus reconstitution

Publications (1)

Publication Number Publication Date
GB9916794D0 true GB9916794D0 (en) 1999-09-22

Family

ID=10857427

Family Applications (1)

Application Number Title Priority Date Filing Date
GBGB9916794.2A Ceased GB9916794D0 (en) 1999-07-14 1999-07-16 In vitro virus reconstitution

Country Status (4)

Country Link
JP (1) JP4850375B2 (en)
DE (1) DE122011100041I1 (en)
GB (1) GB9916794D0 (en)
PT (1) PT1194580E (en)

Families Citing this family (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US11865172B2 (en) 2005-04-21 2024-01-09 University Of Florida Research Foundation, Inc. Materials and methods for respiratory disease control in canines
US7959929B2 (en) 2005-04-21 2011-06-14 University Of Florida Research Foundation, Inc. Materials and methods for respiratory disease control in canines
KR101597534B1 (en) * 2005-10-19 2016-02-26 유니버시티 오브 플로리다 리서치 파운데이션, 인크. Materials and methods for controlling respiratory diseases in canines
CN102666860B (en) * 2009-07-31 2015-06-17 诺华股份有限公司 Reverse genetics systems
PL2491117T3 (en) * 2009-10-20 2014-05-30 Novartis Ag Improved reverse genetics methods for virus rescue
CN104704112A (en) * 2012-08-03 2015-06-10 赛诺菲巴斯德 Production of infectious influenza virus

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP2345716B1 (en) * 1999-04-06 2015-01-14 Wisconsin Alumni Research Foundation Recombinant influenza viruses for vaccines and gene therapy

Also Published As

Publication number Publication date
JP2003520573A (en) 2003-07-08
PT1194580E (en) 2007-03-30
DE122011100041I1 (en) 2011-11-10
JP4850375B2 (en) 2012-01-11

Similar Documents

Publication Publication Date Title
BE2018C020I2 (en)
BE2013C020I2 (en)
BE2008C046I2 (en)
BE1025464I2 (en)
BRPI0017527B8 (en)
JP2002520147A5 (en)
JP2003517651A5 (en)
BRPI0001672A2 (en)
JP2002516667A5 (en)
BRPI0001542A2 (en)
JP2002533005A5 (en)
JP2002503021A5 (en)
JP2002516812A5 (en)
JP2003513872A5 (en)
JP2002518772A5 (en)
DE60015325D1 (en) Offset-kompensation in analog-digital wandlern
BRPI0012675B8 (en)
GB9916794D0 (en) In vitro virus reconstitution
HU0004414D0 (en)
GB0029783D0 (en) Arrangement in moving crusher
GB2349803B (en) Improvements in shelving
GB9925432D0 (en) Virus preparation
GB9927353D0 (en) Virus preparation and use
TW392472U (en) Structural improvement in chair
TW379587U (en) Structural improvement in dice-shaking cup

Legal Events

Date Code Title Description
AT Applications terminated before publication under section 16(1)